Skip to main content

Felix Auger-Aliassime of Canada in action against Alexander Zverev of Germany during the Men's singles second round of 2019 China Open at the China National Tennis Center on Oct. 3, 2019 in Beijing, China.

Lintao Zhang/Getty Images

Canadians improved to 4-0 at the Shanghai Masters after wins by Félix Auger-Aliassime and Vasek Pospisil on Tuesday.

Vancouver’s Pospisil won his second match in as many days and just his third match of the season after back surgery as he prevailed 6-3, 7-5 over Portugal’s Joao Sousa in the second round.

Montreal’s Auger-Aliassime was leading qualifier Alexander Bublik of Kazakhstan 7-6 (5), 4-0 when the latter player retired.

Story continues below advertisement

Pospisil’s win over the 63rd-ranked Sousa currently has him shooting up 59 spots in the rankings after starting the week at No. 248.

Pospisil won 31 of 34 points when he got his first serve in, including 15 aces.

The 29-year-old Pospisil will face No. 3 seed Daniil Medvedev of Russia in the third round.

The 19-year-old Auger-Aliassime, ranked a career-high 19th this week, saved 12 of 14 break points to fend off a challenge from the 54th-ranked Bublik.

Auger-Aliassime will meet No. 6 seed Stefanos Tsitsipas of Greece in the second round on Wednesday. The Canadian is 2-0 lifetime against the 21-year-old Tsitsipas, winning earlier this year at Indian Wells, Calif., (hard court) and London/Queen’s Club (grass court).

Denis Shapovalov of Richmond Hill, Ont., will face top-ranked Novak Djokovic of Serbia in the second round on Wednesday.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter